Completed NA INTERVENTIONAL 2-arm NCT00802451

Bioavailability Study of Two Mesalamine 4 gm/60 ml Rectal Enema Formulations

A Study to Evaluate the Relative Bioavailability of Two Mesalamine 4 gm/60 ml Rectal Enema Formulations

Sponsor: Padagis LLC

Conditions Healthy

Interventions Mesalamine

Updated 7 times since 2017 Last updated: Oct 7, 2021 Started: Feb 28, 2003 Primary completion: Mar 31, 2003 Completion: Mar 31, 2003

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00802451, this NA trial focuses on Healthy and remains completed. Sponsored by Padagis LLC, it has been updated 7 times since 2003, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Nov 2021 — Jul 2024 [monthly]

Completed NA
Jan 2021 — Nov 2021 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed NA
Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Feb 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Padagis LLC

Data source: Padagis LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.